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136Endoscopic versus open saphenous vein graft
harvest for lower extremity bypass in critical limb
ischemia
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Objective: Endoscopic vein harvest (EVH) has been demonstrated to improve early morbidity when compared with
conventional open vein harvest (OVH) technique for infrainguinal bypass surgery. However, recent literature suggests
conﬂicting results regarding mid- and long-term patency with EVH. The purpose of this study is to compare graft patency
between harvest techniques speciﬁcally in patients with critical limb ischemia.
Methods: This retrospective study compared two groups of patients (EVH [ 39 and OVH [ 49) undergoing lower
extremity revascularization from January 2009 to December 2011. Outcome measures included patency rates, post-
operative complications, and wound infection. Graft patency was assessed using Kaplan-Meier curves.
Results: Both groups were matched for demographics and indications for bypass (critical limb ischemia). Median
follow-up was 22 months. There was a signiﬁcant reduction in the incidence of wound infection at the vein harvest site in
the EVH group (OVH [ 20%; EVH [ 0%; P < .001), nevertheless, the difference was not signiﬁcant when only the
anastomotic sites were included (OVH [ 12.2%; EVH [ 15.4%; P [ .43). The hospital length of stay was comparable
between the two groups (EVH [ 8.73 6 9.69; OVH [ 6.35 6 3.28; P [ .26) with no signiﬁcant difference in the
recovery time. Primary graft patency rate was 43.2% in the EVH group and 69.4% in the OVH group (P [ .007) at
3 years. The most common reason for loss of primary patency was graft occlusion (61.5%) in the OVH group and vein
graft stenosis (54.5%) in the EVH group. The average number of vascular reinterventions per bypass graft was signiﬁ-
cantly lower in the OVH group compared with the EVH group (OVH [ 0.37; EVH [ 1.28; P < .001).
Conclusions: Our ﬁndings demonstrate inferior primary patency when using the technique of EVH. Additionally, we
identiﬁed a signiﬁcantly higher rate of reintervention in the EVH cohort as well as a higher rate of vein graft body
stenosis. However, EVH was associated with a decreased rate of wound complications with similar limb salvage and
secondary patency rates when compared to OVH. EVH should therefore be selectively utilized in patients at high risk for
wound complications. (J Vasc Surg 2014;59:136-44.)Saphenous vein grafts have been established as the gold
standard conduit for lower extremity bypass grafting.1
Conventionally, the great saphenous vein (GSV) is typically
harvested via a long continuous or “skip” incisions that
may extend from the groin to the ankle, before its use as
an arterial conduit. This approach, however, is associated
with signiﬁcant morbidities including surgical site infec-
tions, ischemic skin ﬂaps, fat necrosis, lymph leak, increased
postoperative pain, and longer hospital length of stay
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literature, wound complications in vascular patients are
even further compounded by arterial and venous insufﬁ-
ciency, diabetes, and redo operations, conditions fre-
quently exhibited by this patient population.
Minimally invasive vein harvesting techniques were
initially introduced in 1994 and have been developed to
reduce the wound morbidity associated with open vein
harvest (OVH).4 Studies have shown reduced rates of post-
operative wound complications, decreased hospital LOS,
and reduced overall cost following endoscopic vein harvest
(EVH) compared with traditional vein harvest.5-9
The patency rates of lower extremity bypass grafts har-
vested endoscopically were initially reported to parallel that
of standard open technique, with 5-year primary patency
rates ranging from 51% to 73% and secondary patency
from 68% to 81%10-14 However, recently, there have
been multiple reports both in the cardiac as well as in the
vascular surgery literature, showing inferior long-term
patency rates and increased rates of interventions with
EVH.15-17 These reports either included short harvest
segments for coronary grafting or a heterogeneous vascular
population of claudicants and patients with critical limb
ischemia (CLI). On the basis of all these mixed and con-
ﬂicting results, we reviewed our experience to evaluate
differences in patency and to investigate differences in the
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patients treated for CLI.
METHODS
Patients. The study was reviewed and approved by the
Institutional Review Board at the University of Pittsburgh.
A retrospective analysis of consecutive patients undergoing
lower extremity revascularization with saphenous vein
grafts for CLI at the University of Pittsburgh Medical
Center between 2009 and 2011 was performed. Eighty-
eight patients were identiﬁed of whom 39 underwent an
infrainguinal bypass using EVH and 49 had an OVH.
Patients in the EVH group were mainly treated by one of
the investigators (R.C.), who preferentially uses EVH on
all-comers, with no set selection criteria. Exclusion criteria
included the use of spliced veins (ﬁve patients in the EVH
group and four patients in the OVH group), synthetic
composite grafts, in addition to indication for bypass other
than CLI. This includes seven patients in the EVH group
(ﬁve claudicants, two traumatic injury) and 12 patients in
the OVH group (all claudicants).
Preoperative clinical characteristics, operative data, and
postoperative outcomes were collected and analyzed
between the OVH and EVH groups. All patients in both
groups underwent a preoperative duplex saphenous vein
mapping to determine the quality and the suitability of
the vein. A single experienced cardiac surgery physician
assistant who routinely performs EVHs for coronary artery
bypass grafts (CABGs) for more than 10 years performed
all EVHs (M.K.). All OVHs were done through a single
long incision. The OVH control group included consecu-
tive patients treated in the same time period for CLI and
were performed by a single vascular surgeon (S.L.), usually
with the assistance of a resident.
Surgical procedure. For EVH, patients were placed in
a supine position and a transverse stab incision was made at
the medial tibial condyle. Sharp dissection was then carried
to identify the GSV, which was then elevated with a vessel
loop. Another stab incision was made in the groin to
disconnect the saphenous vein from the saphenofemoral
junction. In patients where the calf portion of the vein
was also harvested by redirecting the catheter caudally,
a separate stab incision was made at the medial calf to
disconnect and ligate the vein distally. An ankle incision
was not typically used. EVH was performed with the
disposable VASOVIEW 7 EVH System (Maquet Inc,
Wayne, NJ), using a carbon dioxide insufﬂation technique
(ﬂow set at 5, and pressure of 12 mm Hg) in the perive-
nous tunnel created by the camera dissector. Bipolar elec-
tric cautery (set at 25) was employed to divide side
branches in situ with silk ties applied prior to grafting.
During blunt tip dissection, a regular sequence of short
gentle motions is performed, allowing the CO2 to promote
dissection and ensuring that side branches are dissected
thoroughly to allow adequate length for branch division.
By providing an adequate margin and keeping electrocau-
tery energy settings on the lowest possible settings, the
risk of thermal injury is minimized. Once removed, theGSV is dilated and preserved with Plasma-lyte solution
(Baxter International, Inc, Deerﬁeld, Ill) until ready to be
used. All EVH procedures were performed by the same
physician assistant who has performed over 200 EVH cases.
Saphenous vein grafts harvested using either technique,
when used in nonreversed fashion, underwent a similar val-
vulotomy technique, using the Mills valvulotome.
Follow-up. Post-bypass, all patients were imaged either
with an intraoperative completion angiogram or a duplex
ultrasound prior to discharge. Subsequent surveillance
duplex ultrasound and Doppler studies were obtained at
the ﬁrst follow-up visit and every 3 to 6 months for the
ﬁrst postoperative year, then annually. If bypass grafts were
judged to be at risk of failure, a more frequent surveillance
regimen was implemented at the discretion of the vascular
surgeon. The surveillance protocol and threshold for inter-
vention were similar in both groups and were based on our
established vascular laboratory surveillance protocol.
Vein graft stenosis was determined based on physical
examination and duplex ultrasonography at each follow-
up visit. Worrisome physical examination ﬁndings (ie, loss
of graft pulsatility), or duplex ﬁndings of a peak systolic
velocity >200 cm/s, a velocity ratio >3.0, a graft veloci-
ty <35 cm/s, or an ankle-brachial index drop by >0.15,
led to angiographic evaluation and possible reintervention.
The primary patency rate was calculated from the date of
last known graft patency as conﬁrmed by duplex imaging or
an ankle pressure previously known to correlate with
a duplex-conﬁrmed patent graft. Standard deﬁnitions of
primary, primary-assisted, and secondary patency rates
were used as previously described according to the Ruther-
ford criteria.18 Primary patency was deﬁned as the absence of
restenosis, occlusion, or reintervention in the treated arterial
segment. The primary patency for any intervention ended
when there was clear evidence of occlusion on imaging, if
there was a need for repeat endovascular intervention,
surgical bypass, or major amputation. Primary-assisted
patency for each intervention was achieved via repeat/
secondary endovascular interventions to treat restenosis
involving the originally treated arterial segment. Additional
procedures to treat lesions proximal or distal to the initially
treated segment were also considered secondary interven-
tions to achieve primary-assisted patency. Secondary patency
for each intervention was achieved using repeat endoluminal
intervention to recannalize occluded arterial segments or by
performing open surgical bypass. Patency rates were calcu-
lated using Kaplan-Meier and log-rank test for signiﬁcance.
Postoperative wound complications were classiﬁed
using a modiﬁcation of the Szilagyi’s description. Concisely,
class I wound infection is characterized by erythema
requiring antibiotics treatment, class II wounds were
deﬁned with either drainage or superﬁcial dehiscence, and
class III wounds were described as one with exposed or
threatened grafts.19
Statistics. Continuous data are presented as median
with interquartile range. Categorical data are presented as
frequency and percent. The groups were compared for
signiﬁcant differences by using the c2/Fisher exact test
Table I. Baseline demographic characteristics
EVH (n ¼ 39) OVH (n ¼ 49) P value
Age, years 70.9 6 11.0 72.4 6 11.6 .55
Sex, male 25 (67.6) 29 (59.2) .43
Race
White 35 (89.7) 44 (89.8) .69
Black 2 (5.1) 5 (10.2) .34
Other 2 (5.1) 0 (0)
BMI 27.0 6 5.5 27.7 6 6.1 .60
Smoking status
Never 11 (29.7) 18 (36.7) .33
Former 15 (40.5) 23 (46.9) .33
Current 11 (29.7) 8 (16.3) .20
BMI, Body mass index; EVH, endoscopic vein harvest; OVH, open vein
harvest.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
Table II. Preoperative clinical characteristics
EVH
(n ¼ 39),
No. (%)
OVH
(n ¼ 49),
No. (%) P value
Diabetes 17 (45.9) 30 (61.2) .16
Renal function
Chronic kidney disease 3 (8.1) 10 (20.4) .12
End-stage renal disease 1 (2.7) 3 (6.1) .63
Hypertension 30 (81.1) 44 (89.8) .25
Hyperlipidemia 26 (70.3) 30 (61.2) .38
Coronary artery disease 25 (67.6) 33 (67.3) .98
Prior CABG 7 (18.9) 11 (22.4) .69
Congestive heart failure 13 (35.1) 14 (28.6) .52
Previous MI 16 (43.2) 14 (28.6) .16
Atrial ﬁbrillation 10 (27.0) 21 (42.9) .13
COPD 4 (10.8) 9 (18.4) .33
Prior CVA/TIA 10 (27.0) 12 (24.5) .79
Neuropathy 13 (35.1) 16 (32.7) .81
Connective tissue disease 2 (5.4) 1 (2.0) .58
History of malignancy 8 (21.6) 8 (16.3) .53
CABG, Coronary artery bypass graft; COPD, chronic obstructive pulmo-
nary disease; CVA, cerebrovascular accident; EVH, endoscopic vein harvest;
MI, myocardial infarction; OVH, open vein harvest; TIA, transient ischemic
attack.
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uous data. Patency was analyzed by Kaplan-Meier survival
curves with log-rank (Mantel-Cox) test. Categorical vari-
ables were tested for signiﬁcance using the c2 test. All data
were analyzed with the intention-to-treat principle. A P
value of <.05 was considered signiﬁcant. All analyses were
conducted with SPSS v 19.0 (SPSS Inc, Chicago, Ill). All
statistical analyses were performed by a biostatistician from
the Clinical and Translational Science Institute at the
University of Pittsburgh.
RESULTS
Patient factors. From January 2009 to December
2011, 39 patients underwent lower extremity revasculari-
zation using EVH and 49 patients had OVH. Preoperative
demographics and clinical characteristics of patients in both
groups were comparable. Speciﬁcally, no signiﬁcant differ-
ences were found in age, sex, race, body mass index,
tobacco use (Table I), diabetes, baseline renal function,
hypertension, hyperlipidemia, coronary artery disease, and
cerebrovascular accidents (Table II).
All patients underwent lower extremity bypass surgery
for CLI (Table III). Patients routinely underwent vein
mapping to determine the quality and vein size prior to
the bypass surgery. Vein characteristics were not different
in both groups with more than 75% of veins used between
3 and 5 mm in size. In addition, only 11.1% of veins used in
the EVH group and 6.1% in the OVH group had limited
varicose segments, as determined by preoperative duplex
saphenous vein mapping. Preoperative ankle brachial index
and toe pressures were also comparable (Table IV).
Operative characteristics. Operative time was longer
in the endoscopic harvest group (392.1 6 89.7 minutes)
compared with the OVH group (195.6 6 57.5 minutes)
(P < .001). The EVH was performed at the start of the
case prior to anastomotic site exposure to avoid loss of
gas insufﬂation. Estimated blood loss was comparable
between the two groups (EVH ¼ 214.9 6 134.3;
OVH ¼ 284.7 6 193.7; P ¼ .02) with only 13.5% and
14.3% of patients requiring intraoperative blood transfu-
sions in the EVH and OVH groups, respectively. Most
bypasses were performed using the GSV in a nonreversed
fashion (EVH ¼ 81.1%; OVH ¼ 61.3%). Only one patient
had the lesser saphenous vein used and one patient had in
situ GSV, both in the OVH group. Bypass grafts were
tunneled subcutaneously in both groups. Revascularization
tended to be for more proximal lesions in the EVH group
compared with the OVH group and often required femoral
reconstruction as further detailed in Table V. Additionally,
patients in the EVH group were more likely to receive
a completion intraoperative angiogram.
Postoperative course and complications. Hospital
LOS was not different between the two groups, with
a mean hospital LOS of 8.73 6 9.69 days for the EVH
and 6.35 6 3.28 days for the OVH (P ¼ .26). Although
not statistically signiﬁcant, EVH patients had a trend
toward quicker recovery with more patients discharged
to home, whereas OVH patients were more likely to bedischarged to skilled nursing facilities. No statistically
signiﬁcant difference was found between the two groups
in the incidence of postoperative acute renal failure,
myocardial infarction, cerebrovascular accidents, respira-
tory complications, and death. One (2.0%) of 49 patients
in the OVH group died of a presumed myocardial infarc-
tion on postoperative day 2 (Table VI).
Wound complications. Postoperative wound compli-
cations were characterized using a modiﬁcation of the
Szilagyi’s classiﬁcation. Overall, the total incidence of
wound complications was 16.2% (6/39) in the EVH group
and 22.9% (11/49) in theOVHgroup (P¼ .31) (Table VI).
No patient developed stage III wound infection with
associated threatened graft. Both groups had a similar rate
of wound infection at the anastomotic exposure site
(EVH ¼ 15.4% vs OVH ¼ 12.2%; P ¼ .43) however, the
Table III. Indications for surgery
EVH (n ¼ 39),
No. (%)
OVH (n ¼ 49),
No. (%) P value
Rest pain 16 (41.0) 9 (18.4) .18
Ulcer 19 (48.7) 33 (67.3) .11
Gangrene 4 (10.3) 7 (14.3) .54
EVH, Endoscopic vein harvest; OVH, open vein harvest.
Table IV. Vein characteristics and preoperative
evaluation
EVH (n ¼ 39) OVH (n ¼ 49) P value
Vein size .20
<3 mm 4 (11.1) 10 (20.4)
3-5 mm 27 (75) 37 (75.5)
>5 mm 5 (13.9) 2 (4.1)
Vein quality .45
Normal 32 (88.9) 46 (93.9)
Varicose 4 (11.1) 3 (6.1)
ABI 0.60 6 0.29 0.64 6 0.48 .41
Toe pressures 30.8 6 29.8 21.3 6 18.9 .83
ABI, Ankle brachial index; EVH, endoscopic vein harvest; OVH, open vein
harvest.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
Table V. Operative characteristics
EVH
(n ¼ 39)
OVH
(n ¼ 49)
P
value
Surgery time, minutes 392.1 6 89.7 195.6 6 57.5 <.001
EBL, mL 214.9 6 134.3 284.7 6 193.7 .02
Intraop transfusion 5 (13.5) 7 (14.3) .92
Conduit type .14
Reversed GSV 7 (18.9) 17 (34.7)
Nonreversed GSV 30 (81.1) 30 (61.3)
In situ GSV 0 (0) 1 (2)
LSV 0 (0) 1 (2)
Vein tunneling .10
Anatomic 8 (21.6) 23 (46.9)
Subcutaneous 29 (78.4) 25 (51.0)
In situ 0 (0) 1 (2)
Proximal anastomosis .03
Common femoral 12 (30.7) 10 (20.4)
Superﬁcial femoral 12 (30.7) 7 (14.3)
Deep femoral 5 (12.8) 7 (14.3)
Popliteal 10 (25.6) 25 (51.0)
Distal anastomosis .01
Above-knee popliteal 4 (10.2) 3 (6.1)
Below-knee popliteal 13 (33.3) 7 (14.3)
Anterior tibial 6 (15.3) 12 (24.5)
Posterior tibial 4 (10.2) 1 (2.0)
Peroneal 7 (17.9) 10 (20.4)
Pedal/plantar 5 (12.8) 16 (32.7)
EBL, Estimated blood loss; EVH, endoscopic vein harvest; GSV, great
saphenous vein; LSV, long saphenous vein; OVH, open vein harvest; SD,
standard deviation.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
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at the vein harvest incision site (EVH ¼ 0% vs OVH ¼
20.4%; P < .001). Three of the 10 patients in the OVH
group with vein harvest site wound infection had stage II
wound infections requiring intravenous antibiotics and local
wound care, and the rest only required oral antibiotics.
Reinterventions, patency, and limb salvage. One
EVH (2.5%) patient and two OVH patients (4.1%)
required operative intervention within the early postopera-
tive period (<30 days) (P ¼ .49). The EVH patient devel-
oped thrombosis of the graft on postoperative day 1,
requiring a return to the operating room for successful
graft thrombectomy. The two OVH patients needed oper-
ative intervention for groin hematomas secondary to suture
line bleeding with associated graft thrombosis. Late graft
stenosis (>30 days) was treated with percutaneous or oper-
ative interventions. In the EVH group, 19/39 patients and
in the OVH group, 8/49 patients had evidence of graft
stenosis during the study period at a mean follow-up of
22.8 months after the initial bypass. In the EVH group,
four patients underwent open revision of their bypass grafts
and one patient had a balloon angioplasty for a proximal
stenosis and a simultaneous open jump graft for a severe
distal lesion; the remaining (15) underwent successful
endovascular interventions for severe stenosis identiﬁed on
duplex ultrasound imaging and conﬁrmed by angiography.
In the OVH group, three of eight patients underwent
endovascular interventions, whereas the rest underwent
open revision. Graft occlusions were also treated with
percutaneous or operative interventions. Overall, nine
patients in the EVH group (23%) had evidence of graftocclusion compared with eight patients (16.3%) in the
OVH group. In the EVH group, percutaneous interven-
tion was attempted and successful in two of the nine
patients, while ﬁve patients had surgical intervention with
graft revision. One patient underwent a below-knee
amputation, and one patient was found to have graft
occlusion, however, did not require any intervention and
was asymptomatic. In the OVH group, four patients
underwent surgical revision of their bypass, three patients
underwent a below-knee amputation, while one patient
underwent an above-knee amputation for an overwhelming
soft tissue infection despite a patent graft. Table VII
summarizes the interventions performed on failing grafts.
Patency rates were signiﬁcantly better in the OVH
compared with the EVH group. The primary patency rate
was 43.2% in the EVH group and 69.4% in the OVH group
at a mean follow-up of 30 months (P ¼ .007) (Fig 1). At
30 months, the primary-assisted patency was 75.7% in the
EVH group and 100.0% in the OVH group (P ¼ .001)
(Fig 2), and secondary patency was 100.0% for the EVH
group and 93.9% for the OVH group (P ¼ .12) (Fig 3).
In addition to differences in patency rates, both groups
demonstrated signiﬁcant disparities in the etiology of graft
failure. Themost common reason for loss of primary patency
in the OVH group was graft occlusion (OVH ¼ 57.2%;
EVH¼ 22.7%; P¼ .04), whereas the most common reason
for loss of primary patency in the EVH group was midgraft
stenosis (EVH ¼ 54.5%; OVH ¼ 0%; P < .001). The
Table VI. Thirty-day outcomes
EVH
(n ¼ 39)
OVH
(n ¼ 49)
P
value
Postop ABI 0.94 6 0.27 0.91 6 0.27 .98
Postop toe pressures 67.11 6 32.1 49.6 6 34.9 .02
Hospital LOS 8.73 6 9.69 6.35 6 3.28 .26
Postop disposition .29
Home 26 (70.3) 29 (59.1)
Nursing facility 11 (29.7) 20 (40.8)
Mortality 0 (0) 1 (2.0) .57
MI 0 (0) 2 (4.2) .50
Renal failure 2 (5.4) 3 (6.3) 1.00
Pneumonia 1 (2.7) 0 (0) .44
CVA/TIA 0 (0) 1 (2.1) 1.00
UTI 1 (2.7) 2 (4.2) 1.00
DVT 0 (0) 0 (0)
Wound infections
Total 6 (16.2) 11 (22.9) .31
Vein harvest site 0 (0) 10 (20.4) <.001
Surgery site 6 (15.4) 6 (12.2) .43
Average no. of
interventions/graft
1.286 1.59 0.37 6 0.85 <.001
Reason for graft failure
Inﬂow/outﬂow disease 3 (13.7) 3 (21.4) .18
Anastomotic stenosis 2 (9.1) 3 (21.4) .05
Midgraft stenosis 12 (54.5) 0 (0) <.001
Graft occlusion 5 (22.7) 8 (57.2) .04
Major amputations
(BKA/AKA)
1 (2.5) 4 (8.1) .34
ABI, Ankle brachial index; AKA, above-knee amputation; BKA, below-
knee amputation; CVA, cerebrovascular accident; DVT, deep venous
thrombosis; EVH, endoscopic vein harvest; LOS, length of stay; MI,
myocardial infarction OVH, open vein harvest; TIA, transient ischemic
attack; UTI, urinary tract infection.
Continuous data are presented as mean 6 standard deviation and categoric
data as number (%).
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was signiﬁcantly lower in the OVH group compared with
the EVH group (OVH ¼ 0.37; EVH ¼ 1.28; P < .001).
Limb salvage rate was not different between the two groups
with one patient (2.5%) in the EVH group and four patients
(8.1%) in the OVH group undergoing major amputations
following revascularization (P ¼ .34) (Table VI).
DISCUSSION
EVH techniques have been developed in an attempt to
decrease the morbidity associated with OVH. This study
reviews our experience over the past 3 years of patients
undergoing lower extremity bypass surgery for CLI with
endoscopic vs open saphenous vein harvest. We found
our results to partially support previously published ﬁnd-
ings. Consistent with previous studies, our study conﬁrms
that EVH was associated with decreased wound infection
at the vein harvest site. However, primary patency rates
were signiﬁcantly lower with an increased frequency of
reinterventions in the EVH group compared with the
OVH group. No difference in limb salvage or hospital
LOS was noted between the two groups.
EVH was explored in the early 1990s by cardiac
surgeons and quickly became the standard of care forCABG. Multiple early reports in the cardiac literature have
shown reduced postoperative morbidities and wound
complications associated with EVH with no compromise
on graft patency.20,21 By 2005, EVH was used in 80% of
coronary bypasses in the United States.14 The situation
was different for the vascular community for numerous
reasons and currently, only about 10% to 20% of vascular
surgeons utilize EVH for lower extremity bypass grafts.17
During a CABG procedure, both the cardiac surgeon and
the assistant are able to operate simultaneously. This is
distinctly different in lower extremity bypasses where vein
harvesting occurs in the same physical space as the arterial
exposure, rendering insufﬂation and seal challenging for
EVH. The inability to simultaneously harvest vein and
expose the anastomotic sites substantially increases opera-
tive time. In addition, any vein injury, either in the form
of pressure, traction, burn, or sharp trauma is more signiﬁ-
cant for the longer bypasses used in the extremities, which
require a longer segment of harvested vein. On the other
hand, in CABG, shorter vein length is satisfactory and focal
injuries can be excluded and discarded. The use of harvest-
ing techniques with no insufﬂation developed to minimize
some of the above problems, also presents inherent hurdles.
Although they minimize complications associated with
increased operating time and potential injury to the vein
from insufﬂation pressure, such techniques may be limited
by less visualization and exposure. This may require addi-
tional traction on the vein for optimal exposure potentially
resulting in increased vein injury and reduced graft patency.
In contrast to the abundant evidence demonstrating the
short-term and wound related complications after EVH,
there is a paucity of data regarding graft patency or clinical
outcomes comparing both modalities. While earlier studies
reported comparable patency rates and outcomes following
EVH, there have been a number of recent reports showing
reduced graft patency following EVH when compared
with the traditional open technique. Two recent studies
looked at short- and long-term outcomes of lower extremity
bypasses using saphenous veins harvested either endoscopi-
cally or by open technique. They showed inferior patency
rates for endoscopically harvested saphenous veins after
lower extremity bypasses without conﬁrming the short-
term beneﬁts previously reported, speciﬁcally hospital LOS
and wound complication rates.15,17 Even more surprisingly,
two recent reports in the cardiac literature by Lopes et al and
Zenati et al showed similar results.16,22 Disputing earlier
reports, they demonstrated inferior graft patency with an
associated increased need for repeat revascularization,
occurrence of myocardial infarction, and death in patients
undergoing endoscopic harvest. Our results were compa-
rable and further support those reports. While our results
showed improved wound complication rates at the vein
harvest site, other short-term outcomes such as 30-day
mortality and morbidities were comparable between both
groups. In addition, the previously reported impact of
EVH on improved recovery was not evident in our study,
even though both groups were comparable in terms of social
support and comorbidities. A larger cohort study may be
Table VII. Management of failing grafts
Interventions
Primary/primary-assisted patency, No. (%) Secondary patency, No. (%)
EVH (n ¼ 19) OVH (n ¼ 8) EVH (n ¼ 9) OVH (n ¼ 8)
Balloon angioplasty 16 (41.0) 3 (6.12) 5 (12.8) 1 (2.04)
Open surgical bypass 1 (2.56) 2 (4.08) 3 (7.69) 3 (6.12)
Patch angioplasty 0 (0) 0 (0) 2 (5.12) 0 (0)
Interposition graft 2 (5.12) 3 (6.12) 3 (7.69) 0 (0)
Thrombectomy 1 (2.56) 0 (0) 3 (7.69) 2 (4.08)
Observation 0 (0) 1 (2.04) 1 (2.56) 0 (0)
Major amputation 0 (0) 0 (0) 1 (2.56) 4 (8.16)
EVH, Endoscopic vein harvest; OVH, open vein harvest.
Fig 1. Comparison of primary patency between endoscopic vein
harvest (EVH) and open vein harvest (OVH) by Kaplan-Meier
survival analysis (P ¼ .07).
Fig 2. Comparison of primary-assisted patency between endo-
scopic vein harvest (EVH) and open vein harvest (OVH) by
Kaplan-Meier survival analysis (P ¼ .001).
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niques on recovery period and hospital LOS. More signiﬁ-
cantly, patients undergoing EVH were more susceptible to
graft failure and required increased rates of interventions.
In addition, our study provides novel evidence on the
pattern of graft failure following lower extremity bypass
using different harvesting techniques, speciﬁcally in the
EVH group. While it has been previously known that graft
failure occurs commonly at the anastomotic sites, we provide
convincing evidence that patients undergoing EVH have
a signiﬁcantly higher rate of vein body stenosis compared
with OVH (Fig 4). These results highlights the potential
risk associated with EVH, which has been alluded to in other
reports.23-25
Critics of EVH argue that this technique causes signif-
icant trauma to the vein. Although early studies showed no
signs of intimal injury on histology,26 recent evidence using
multiphoton imaging and immunoﬂuorescence staining
suggested evidence of structural and functional impairment
of endothelial cells, leading to graft failure.23-25 EVHcommonly requires insufﬂation in addition to bipolar
cautery in the vicinity of the vein, both of which are not
required in OVH. Thermal energy has been proposed to
cause injury to the vessel wall and impair the quality of
the graft by damaging the endothelial cells leading to
intimal hyperplasia and graft stenosis. Traction may also
be associated with signiﬁcant mechanical injury to the
vein graft. This is somewhat supported by our ﬁndings
that graft stenosis in the EVH group was more commonly
seen in the body of the bypass graft, likely at the site of
cauterization of large branches, whereas in the OVH
group, it was more localized to the anastomosis, which is
what has been traditionally described as a cause of graft
stenosis and failure. It is noteworthy that despite the infe-
rior patency rates observed in the EVH group, limb salvage
and amputation-free survival were similar between the two
groups. This was compensated for by increased open and
endovascular interventions, more commonly in the
EVH group. Graft salvage was made possible by close
surveillance in the postoperative period and aggressive
Fig 3. Comparison of secondary patency between endoscopic vein
harvest (EVH) and open vein harvest (OVH) by Kaplan-Meier
survival analysis (P ¼ .117).
Fig 4. Representative angiogram of two different bypass grafts
harvested endoscopically with stenosis in the body of the vein. The
arrows point to the area of stenosis.
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our current study or other previous reports, this potentially
leaves a role and value for EVH in speciﬁc situations or
patient population at high risk for wound morbidity with
OVH, and should not be completely abandoned, particu-
larly for morbidly obese patients, reoperative ﬁelds, and
contralateral leg harvest.27,28 Furthermore, since its intro-
duction in the mid-1990s, EVH has undergone many
transformations with both reﬁnement in the harvesting
technique and vessel handling, in addition to technological
advancement with easier and more protective features.
New-generation EVH systems have been developed to
minimize endothelial cell damage secondary to “thermal
spread.” They use a bipolar radiofrequency energy source
and are designed to keep thermal spread to a minimum
(less than 1 mm), potentially minimizing graft injury.
However, to date, data are still lacking comparing different
harvesting systems and technologies. The results of this
study have the authors to adopt this selective use of EVH
in their practice for such high-risk patients and have
prompted the adoption of newer-generation EVH systems.
In this retrospective study, several methods were used
to control for potentially confounding factors, which
were not addressed in previous reports. While the learning
curve for EVH was a concern in multiple previous studies,
only a single experienced physician assistant performed all
the EVH in this study. Moreover, all OVH were performed
by a single surgeon, potentially further controlling for
interpersonal variabilities. Furthermore, differences in
conduit caliber and quality were carefully evaluated and
controlled for between the two groups, another critical
confounding variable frequently not addressed in the liter-
ature. As previously mentioned, all patients in our study
underwent preoperative vein mapping to assess the size
and quality of the vein and were comparable between thetwo groups. On the other hand, few variables were
different in our study. While operative time was similar in
previous reports when comparing both harvesting tech-
niques,27 our study had signiﬁcantly longer operative
time for the EVH group. Besides the inability to work
simultaneously during the EVH, a signiﬁcant percentage
of patients (9/39) in the EVH group who had more prox-
imal disease underwent simultaneous femoral endarterec-
tomy at the time of the procedure, adding further to the
operative time. In addition, the bypasses done in the
OVH group were shorter and less frequently accompanied
by a completion angiogram, also diminishing the operative
time.
This study has certain caveats and limitations that
should be considered. This is a retrospective single-center
study, which can allow for bias from unmeasured con-
founders. In addition, patients in both groups were not
randomized, and selection of the harvest technique was
based on the single surgeon’s preference, possibly intro-
ducing a selection bias despite the routine use of one tech-
nique or the other on all-comers by the investigators. In
addition to selection bias, operator bias provides another
limitation to this study. However, we do not believe that
differences in graft patency are due solely to operator differ-
ences. Vascular surgeons participating in this study use
similar exposure, tunneling, hemostasis, and suturing
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 1 Eid et al 143techniques and have previously established comparable
graft patency rates. This leaves methods of vein harvesting
a major contributing factor to differences in outcomes in
our study. However, despite both groups being compa-
rable in major risk factors, interoperator variability may still
introduce a systematic error to the ﬁnal analysis. Further-
more, the sample size is small and could limit our ability
to highlight or identify small differences. Another factor
that may theoretically affect our results and analysis is
that bypasses in the OVH group were more commonly
from the popliteal to tibial or pedal vessels with potentially
shorter overall length of grafts compared with the bypasses
in the EVH group. The importance of economic ramiﬁca-
tions of each harvesting technique was also not addressed
in our study. EVH may be associated with additional costs
in our study such as increased operative time, equipment
cost, and increased reinterventions; however, a more
complete cost analysis should be performed with a larger
cohort study to be able to establish the cost-effectiveness
of each harvesting technique. Despite these limitations,
this study provides valuable novel data looking at the
midterm outcomes and patency of grafts harvested endo-
scopically compared with open techniques.
CONCLUSIONS
This study shows that although EVH may be associ-
ated with a decreased rate of wound complications, it is
associated with inferior graft patency in patients treated
for CLI with an increased incidence of severe stenosis
within the body of the graft requiring reintervention.
However, limb salvage and secondary patency rates are
similar. EVH should, therefore, be selectively used in
patients at high risk for wound complications.
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